+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Targeted DNA RNA Sequencing Market Size, Share & Trends Analysis Report by Workflow (Pre-sequencing, Sequencing, Data Analysis), Technology, Application, Type, End Use and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 150 Pages
  • November 2025
  • Region: Global
  • Grand View Research
  • ID: 5998958
The global targeted DNA RNA sequencing market size was estimated at USD 7.40 billion in 2024 and is projected to reach USD 34.56 billion by 2033, expanding at a CAGR of 18.98% from 2025 to 2033. The market is growing rapidly due to the increasing use of precision medicine, the rising incidence of cancer and genetic diseases, and the demand for more cost-efficient and highly accurate sequencing methodologies that enable the deep analysis of specific genes or genomic regions.

Growing Demand for Precision Diagnostics and Targeted Therapies

With the rising incidences of diseases such as cancer, heart diseases, and genetic disorders, the need to diagnose and develop specific treatments drives the market growth. In targeted sequencing, it is possible to identify pathogenic variations at an earlier stage in the process, which facilitates diagnosis and improves treatment options. This is particularly sensitive if the cancer type can be treated with targeted therapy that may not cause as many side effects as chemotherapy.

Moreover, targeted sequencing facilitates the transition to personalized, less invasive therapies, particularly in the fields of oncology and rare disease. By identifying actionable genetic mutations, clinicians can select targeted therapies that are both more effective and have lower toxicity compared to standard chemotherapy or broad-spectrum treatments. The capacity for individualized care, minimal toxicity, and improved patient outcomes continues to drive the use of targeted sequencing in the clinical, research, and pharmaceutical sectors, making it a major contributor to healthcare innovation and market expansion.

Technological Advancements and Cost Efficiency Accelerating Adoption

Advances in next-generation sequencing platforms, enrichment chemistry, and automation make targeted sequencing faster, more accurate, and significantly less costly. Innovations such as improved capture kits, high-throughput systems, and enhanced reagents are reducing processing and turnaround times, thereby supporting applications in hospitals, research laboratories, and biotech companies.

Moreover, targeted sequencing focuses on only selected gene regions, allowing for deeper coverage and increased sensitivity in detecting rarer variants, which is superior to whole-genome sequencing. Given that targeted sequencing has lower data analysis requirements, fewer storage needs, and cost-efficient workflows, it is increasingly chosen by healthcare providers in areas such as routine diagnostics, precision medicine, and large genomic programs. This value proposition, based on efficiencies, continues to drive market expansion.

Global Targeted DNA RNA Sequencing Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the global targeted DNA RNA sequencing market based on technology, workflow, application, type, end use, and region:

Technology Outlook (Revenue, USD Million, 2021-2033)

  • NGS
  • Others

Workflow Outlook (Revenue, USD Million, 2021-2033)

  • Pre-sequencing
  • Sequencing
  • Data Analysis

Application Outlook (Revenue, USD Million, 2021-2033)

  • Human Biomedical Research
  • Plant & Animal Sciences
  • Drug Discovery
  • Others

Type Outlook (Revenue, USD Million, 2021-2033)

  • DNA Based Targeted Sequencing
  • RNA Based Targeted Sequencing

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Academic Research
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Technology
1.2.2. Workflow
1.2.3. Application
1.2.4. Type
1.2.5. End Use
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Targeted DNA RNA Sequencing Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.1.1. Growing Demand for Precision Diagnostics and Targeted Therapies
3.3.1.2. Technological Advancements and Cost Efficiency Accelerating Adoption
3.3.2. Market Restraints Analysis
3.3.2.1. High Initial Capital Investment
3.4. Business Environment Analysis
3.4.1. PESTLE Analysis
3.4.2. PORTER’S Five Forces Analysis
Chapter 4. Targeted DNA RNA Sequencing Market: Technology Estimates & Trend Analysis
4.1. Technology Segment Dashboard
4.2. Targeted DNA RNA Sequencing Market: Technology Movement Analysis, USD Million, 2023 & 2033
4.3. NGS
4.3.1. NGS Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2. Method Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.1. Exome Sequencing
4.3.2.1.1. Exome Sequencing Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.2. Enrichment Sequencing
4.3.2.2.1. Enrichment Sequencing Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.3. Amplicon Sequencing
4.3.2.3.1. Amplicon Sequencing Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.4. Others
4.3.2.4.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3. Application Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.1. Cancer Gene Sequencing
4.3.3.1.1. Cancer Gene Sequencing Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.2. Inherited Disease Screening
4.3.3.2.1. Inherited Disease Screening Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.3. Drug Development
4.3.3.3.1. Drug Development Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.4. Forensic Genomics
4.3.3.4.1. Forensic Genomics Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.5. 16S Ribosomal RNA (rRNA)
4.3.3.5.1. 16S Ribosomal RNA (rRNA) Sequencing Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.4. Others
4.4.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Targeted DNA RNA Sequencing Market: Workflow Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Targeted DNA RNA Sequencing Market: Workflow Movement Analysis, USD Million, 2023 & 2033
5.3. Pre-sequencing
5.3.1. Pre-sequencing Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.4. Sequencing
5.4.1. Sequencing Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Data Analysis
5.5.1. Data Analysis Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Targeted DNA RNA Sequencing Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Targeted DNA RNA Sequencing Market: Application Movement Analysis, USD Million, 2023 & 2033
6.3. Human Biomedical Research
6.3.1. Human Biomedical Research Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.4. Plant & Animal Sciences
6.4.1. Plant & Animal Sciences Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Drug Discovery
6.5.1. Drug Discovery Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Others
6.6.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Targeted DNA RNA Sequencing Market: Type Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Targeted DNA RNA Sequencing Market: Type Movement Analysis, USD Million, 2023 & 2033
7.3. DNA Based Targeted Sequencing
7.3.1. DNA Based Targeted Sequencing Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.4. RNA Based Targeted Sequencing
7.4.1. RNA Based Targeted Sequencing Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Targeted DNA RNA Sequencing Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Targeted DNA RNA Sequencing Market: End Use Movement Analysis, USD Million, 2023 & 2033
8.3. Academic Research
8.3.1. Academic Research Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
8.4. Hospitals & Clinics
8.4.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
8.5. Pharma & Biotech Entities
8.5.1. Pharma & Biotech Entities Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
8.6. Others
8.6.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 9. Targeted DNA RNA Sequencing Market: Regional Estimates & Trend Analysis
9.1. Targeted DNA RNA Sequencing Market Share, By Region, 2024 & 2033, USD Million
9.2. North America
9.2.1. North America Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2021-2033 (USD Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Competitive Scenario
9.2.2.3. Regulatory Framework
9.2.2.4. U.S. targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Competitive Scenario
9.2.3.3. Regulatory Framework
9.2.3.4. Canada targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.2.4. Mexico
9.2.4.1. Key Country Dynamics
9.2.4.2. Competitive Scenario
9.2.4.3. Regulatory Framework
9.2.4.4. Mexico targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.3. Europe
9.3.1. Europe targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.3.2. UK
9.3.2.1. Key Country Dynamics
9.3.2.2. Competitive Scenario
9.3.2.3. Regulatory Framework
9.3.2.4. UK targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Competitive Scenario
9.3.3.3. Regulatory Framework
9.3.3.4. Germany targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.3.4. France
9.3.4.1. Key Country Dynamics
9.3.4.2. Competitive Scenario
9.3.4.3. Regulatory Framework
9.3.4.4. France targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Competitive Scenario
9.3.5.3. Regulatory Framework
9.3.5.4. Italy targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Competitive Scenario
9.3.6.3. Regulatory Framework
9.3.6.4. Spain targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.3.7. Denmark
9.3.7.1. Key Country Dynamics
9.3.7.2. Competitive Scenario
9.3.7.3. Regulatory Framework
9.3.7.4. Denmark targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.3.8. Sweden
9.3.8.1. Key Country Dynamics
9.3.8.2. Competitive Scenario
9.3.8.3. Regulatory Framework
9.3.8.4. Sweden targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Competitive Scenario
9.3.9.3. Regulatory Framework
9.3.9.4. Norway targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.4. Asia-Pacific
9.4.1. Asia-Pacific targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.4.2. Japan
9.4.2.1. Key Country Dynamics
9.4.2.2. Competitive Scenario
9.4.2.3. Regulatory Framework
9.4.2.4. Japan targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.4.3. China
9.4.3.1. Key Country Dynamics
9.4.3.2. Competitive Scenario
9.4.3.3. Regulatory Framework
9.4.3.4. China targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Competitive Scenario
9.4.4.3. Regulatory Framework
9.4.4.4. India targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.4.5. Australia
9.4.5.1. Key Country Dynamics
9.4.5.2. Competitive Scenario
9.4.5.3. Regulatory Framework
9.4.5.4. Australia targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.4.6. Thailand
9.4.6.1. Key Country Dynamics
9.4.6.2. Competitive Scenario
9.4.6.3. Regulatory Framework
9.4.6.4. Thailand targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.4.7. South Korea
9.4.7.1. Key Country Dynamics
9.4.7.2. Competitive Scenario
9.4.7.3. Regulatory Framework
9.4.7.4. South Korea targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.5. Latin America
9.5.1. Latin America targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Competitive Scenario
9.5.2.3. Regulatory Framework
9.5.2.4. Brazil targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.5.3. Argentina
9.5.3.1. Key Country Dynamics
9.5.3.2. Competitive Scenario
9.5.3.3. Regulatory Framework
9.5.3.4. Argentina targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.6. MEA
9.6.1. MEA targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.6.2. South Africa
9.6.2.1. Key Country Dynamics
9.6.2.2. Competitive Scenario
9.6.2.3. Regulatory Framework
9.6.2.4. South Africa targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Key Country Dynamics
9.6.3.2. Competitive Scenario
9.6.3.3. Regulatory Framework
9.6.3.4. Saudi Arabia targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.6.4. UAE
9.6.4.1. Key Country Dynamics
9.6.4.2. Competitive Scenario
9.6.4.3. Regulatory Framework
9.6.4.4. UAE targeted DNA RNA sequencing market, 2021-2033 (USD Million)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Competitive Scenario
9.6.5.3. Regulatory Framework
9.6.5.4. Kuwait targeted DNA RNA sequencing market, 2021-2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2024
10.4. Company Profiles/Listing
10.4.1. Illumina
10.4.1.1. Participant’s Overview
10.4.1.2. Financial Performance
10.4.1.3. Product Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. F. Hoffman-La Roche Ltd.
10.4.2.1. Participant’s Overview
10.4.2.2. Financial Performance
10.4.2.3. Product Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. QIAGEN
10.4.3.1. Participant’s Overview
10.4.3.2. Financial Performance
10.4.3.3. Product Benchmarking
10.4.3.4. Strategic Initiatives
10.4.4. Thermo Fisher Scientific, Inc.
10.4.4.1. Participant’s Overview
10.4.4.2. Financial Performance
10.4.4.3. Product Benchmarking
10.4.4.4. Strategic Initiatives
10.4.5. Bio-Rad Laboratories, Inc.
10.4.5.1. Participant’s Overview
10.4.5.2. Financial Performance
10.4.5.3. Product Benchmarking
10.4.5.4. Strategic Initiatives
10.4.6. Oxford Nanopore Technologies
10.4.6.1. Participant’s Overview
10.4.6.2. Financial Performance
10.4.6.3. Product Benchmarking
10.4.6.4. Strategic Initiatives
10.4.7. PierianDx
10.4.7.1. Participant’s Overview
10.4.7.2. Financial Performance
10.4.7.3. Product Benchmarking
10.4.7.4. Strategic Initiatives
10.4.8. Genomatix GmbH
10.4.8.1. Participant’s Overview
10.4.8.2. Financial Performance
10.4.8.3. Product Benchmarking
10.4.8.4. Strategic Initiatives
10.4.9. DNASTAR, Inc.
10.4.9.1. Participant’s Overview
10.4.9.2. Financial Performance
10.4.9.3. Product Benchmarking
10.4.9.4. Strategic Initiatives
10.4.10. Perkin Elmer, Inc.
10.4.10.1. Participant’s Overview
10.4.10.2. Financial Performance
10.4.10.3. Product Benchmarking
10.4.10.4. Strategic Initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 4. Global Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 5. Global Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 6. Global Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 7. Global Targeted DNA RNA Sequencing Market, End Use, 2021-2033 (USD Million)
Table 8. Global Targeted DNA RNA Sequencing Market, by Region, 2021-2033 (USD Million)
Table 9. North America Targeted DNA RNA Sequencing Market, by Country, 2021-2033 (USD Million)
Table 10. North America Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 11. North America Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 12. North America Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 13. North America Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 14. North America Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 15. U.S. Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 16. U.S. Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 17. U.S. Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 18. U.S. Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 19. U.S. Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 20. Canada Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 21. Canada Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 22. Canada Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 23. Canada Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 24. Canada Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 25. Mexico Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 26. Mexico Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 27. Mexico Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 28. Mexico Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 29. Mexico Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 30. Europe Targeted DNA RNA Sequencing Market, by Country, 2021-2033 (USD Million)
Table 31. Europe Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 32. Europe Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 33. Europe Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 34. Europe Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 35. Europe Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 36. Germany Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 37. Germany Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 38. Germany Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 39. Germany Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 40. Germany Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 41. UK Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 42. UK Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 43. UK Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 44. UK Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 45. UK Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 46. France Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 47. France Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 48. France Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 49. France Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 50. France Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 51. Italy Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 52. Italy Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 53. Italy Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 54. Italy Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 55. Italy Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 56. Spain Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 57. Spain Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 58. Spain Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 59. Spain Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 60. Spain Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 61. Denmark Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 62. Denmark Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 63. Denmark Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 64. Denmark Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 65. Denmark Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 66. Norway Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 67. Norway Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 68. Norway Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 69. Norway Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 70. Norway Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 71. Sweden Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 72. Sweden Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 73. Sweden Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 74. Sweden Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 75. Sweden Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 76. Asia-Pacific Targeted DNA RNA Sequencing Market, by Country, 2021-2033 (USD Million)
Table 77. Asia-Pacific Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 78. Asia-Pacific Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 79. Asia-Pacific Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 80. Asia-Pacific Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 81. Asia-Pacific Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 82. China Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 83. China Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 84. China Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 85. China Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 86. China Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 87. Japan Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 88. Japan Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 89. Japan Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 90. Japan Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 91. Japan Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 92. India Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 93. India Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 94. India Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 95. India Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 96. India Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 97. South Korea Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 98. South Korea Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 99. South Korea Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 100. South Korea Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 101. South Korea Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 102. Australia Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 103. Australia Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 104. Australia Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 105. Australia Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 106. Australia Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 107. Thailand Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 108. Thailand Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 109. Thailand Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 110. Thailand Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 111. Thailand Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 112. Latin America Targeted DNA RNA Sequencing Market, by Country, 2021-2033 (USD Million)
Table 113. Latin America Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 114. Latin America Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 115. Latin America Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 116. Latin America Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 117. Latin America Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 118. Brazil Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 119. Brazil Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 120. Brazil Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 121. Brazil Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 122. Brazil Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 123. Argentina Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 124. Argentina Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 125. Argentina Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 126. Argentina Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 127. Argentina Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 128. Middle East and Africa Targeted DNA RNA Sequencing Market, by Country, 2021-2033 (USD Million)
Table 129. Middle East and Africa Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 130. Middle East and Africa Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 131. Middle East and Africa Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 132. Middle East and Africa Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 133. Middle East and Africa Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 134. South Africa Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 135. South Africa Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 136. South Africa Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 137. South Africa Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 138. South Africa Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 139. Saudi Arabia Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 140. Saudi Arabia Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 141. Saudi Arabia Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 142. Saudi Arabia Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 143. Saudi Arabia Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 144. UAE Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 145. UAE Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 146. UAE Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 147. UAE Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 148. UAE Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
Table 149. Kuwait Targeted DNA RNA Sequencing Market, by Technology, 2021-2033 (USD Million)
Table 150. Kuwait Targeted DNA RNA Sequencing Market, by Workflow, 2021-2033 (USD Million)
Table 151. Kuwait Targeted DNA RNA Sequencing Market, by Application, 2021-2033 (USD Million)
Table 152. Kuwait Targeted DNA RNA Sequencing Market, by Type, 2021-2033 (USD Million)
Table 153. Kuwait Targeted DNA RNA Sequencing Market, by End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Targeted DNA RNA sequencing market segmentation
Figure 2 Data analysis models
Figure 3 Market formulation and validation
Figure 4 Data validation & publishing
Figure 5 Market research process
Figure 6 Information procurement
Figure 7 Primary research
Figure 8 Value-chain-based sizing & forecasting
Figure 9 QFD modelling for market share assessment
Figure 10 Market formulation & validation
Figure 11 Commodity flow analysis
Figure 12 Market outlook
Figure 13 Segment snapshot-1
Figure 14 Competitive landscape snapshot
Figure 15 Market trends & outlook
Figure 16 PESTEL analysis
Figure 17 Porter’s five forces analysis
Figure 18 Targeted DNA RNA sequencing market: Technology outlook key takeaways
Figure 19 Targeted DNA RNA sequencing market: Technology movement analysis
Figure 20 NGS, 2021-2033 (USD Million)
Figure 21 Exome sequencing, 2021-2033 (USD Million)
Figure 22 Enrichment sequencing, 2021-2033 (USD Million)
Figure 23 Amplicon sequencing, 2021-2033 (USD Million)
Figure 24 Others, 2021-2033 (USD Million)
Figure 25 Cancer gene sequencing, 2021-2033 (USD Million)
Figure 26 Inherited disease screening, 2021-2033 (USD Million)
Figure 27 Drug development, 2021-2033 (USD Million)
Figure 28 Forensic genomics, 2021-2033 (USD Million)
Figure 29 16S ribosomal RNA (rRNA) sequencing, 2021-2033 (USD Million)
Figure 30 Others, 2021-2033 (USD Million)
Figure 31 Targeted DNA RNA sequencing market: Workflow outlook key takeaways
Figure 32 Targeted DNA RNA sequencing market: Workflow movement analysis
Figure 33 Pre-sequencing, 2021-2033 (USD Million)
Figure 34 Sequencing, 2021-2033 (USD Million)
Figure 35 Data Analysis, 2021-2033 (USD Million)
Figure 36 Targeted DNA RNA sequencing market: Application outlook key takeaways
Figure 37 Targeted DNA RNA sequencing market: Application movement analysis
Figure 38 Human Biomedical Research, 2021-2033 (USD Million)
Figure 39 Plant & Animal Sciences, 2021-2033 (USD Million)
Figure 40 Drug Discovery, 2021-2033 (USD Million)
Figure 41 Others, 2021-2033 (USD Million)
Figure 42 Targeted DNA RNA sequencing market: Type outlook key takeaways
Figure 43 Targeted DNA RNA sequencing market: Type movement analysis
Figure 44 DNA Based Targeted Sequencing, 2021-2033 (USD Million)
Figure 45 RNA Based Targeted Sequencing, 2021-2033 (USD Million)
Figure 46 Targeted DNA RNA sequencing market: End use outlook key takeaways
Figure 47 Targeted DNA RNA sequencing market: End use movement analysis
Figure 48 Academic Research, 2021-2033 (USD Million)
Figure 49 Hospitals & Clinics, 2021-2033 (USD Million)
Figure 50 Pharma & Biotech Entities, 2021-2033 (USD Million)
Figure 51 Other Users, 2021-2033 (USD Million)
Figure 52 Regional marketplace outlook, 2024 & 2033, (USD Million)
Figure 53 Regional marketplace: Key takeaways
Figure 54 North America targeted DNA RNA sequencing market estimates and forecast, 2021-2033 (USD Million)
Figure 55 Key country dynamics
Figure 56 U.S. targeted DNA RNA sequencing market estimates and forecast, 2021-2033 (USD Million)
Figure 57 Key country dynamics
Figure 58 Canada targeted DNA RNA sequencing market estimates and forecast, 2021-2033 (USD Million)
Figure 59 Key country dynamics
Figure 60 Mexico targeted DNA RNA sequencing market estimates and forecast, 2021-2033 (USD Million)
Figure 61 Europe targeted DNA RNA sequencing market estimates and forecast, 2021-2033 (USD Million)
Figure 62 Key country dynamics
Figure 63 Germany targeted DNA RNA sequencing market estimates and forecast, 2021-2033 (USD Million)
Figure 64 Key country dynamics
Figure 65 UK targeted DNA RNA sequencing market estimates and forecast, 2021-2033 (USD Million)
Figure 66 Key country dynamics
Figure 67 France targeted DNA RNA sequencing market estimates and forecast, 2021-2033 (USD Million)
Figure 68 Key country dynamics
Figure 69 Italy targeted DNA RNA sequencing market estimates and forecast, 2021-2033 (USD Million)
Figure 70 Key country dynamics
Figure 71 Spain targeted DNA RNA sequencing market estimates and forecast, 2021-2033 (USD Million)
Figure 72 Key country dynamics
Figure 73 Denmark targeted DNA RNA sequencing market estimates and forecast, 2021-2033 (USD Million)
Figure 74 Key country dynamics
Figure 75 Sweden targeted DNA RNA sequencing market estimates and forecast, 2021-2033 (USD Million)
Figure 76 Key country dynamics
Figure 77 Norway targeted DNA RNA sequencing market estimates and forecast, 2021-2033 (USD Million)
Figure 78 Asia-Pacific targeted DNA RNA sequencing market estimates and forecast, 2021-2033 (USD Million)
Figure 79 Key country dynamics
Figure 80 Japan targeted DNA RNA sequencing market estimates and forecasts, 2021-2033 (USD Million)
Figure 81 Key country dynamics
Figure 82 China targeted DNA RNA sequencing market estimates and forecasts, 2021-2033 (USD Million)
Figure 83 Key country dynamics
Figure 84 India targeted DNA RNA sequencing market estimates and forecasts, 2021-2033 (USD Million)
Figure 85 Key country dynamics
Figure 86 South Korea targeted DNA RNA sequencing market estimates and forecasts, 2021-2033 (USD Million)
Figure 87 Key country dynamics
Figure 88 Australia targeted DNA RNA sequencing market estimates and forecasts, 2021-2033 (USD Million)
Figure 89 Key country dynamics
Figure 90 Thailand targeted DNA RNA sequencing market estimates and forecasts, 2021-2033 (USD Million)
Figure 91 Latin America targeted DNA RNA sequencing market estimates and forecasts, 2021-2033 (USD Million)
Figure 92 Key country dynamics
Figure 93 Brazil targeted DNA RNA sequencing market estimates and forecasts, 2021-2033 (USD Million)
Figure 94 Key country dynamics
Figure 95 Argentina targeted DNA RNA sequencing market estimates and forecasts, 2021-2033 (USD Million)
Figure 96 MEA targeted DNA RNA sequencing market estimates and forecasts, 2021-2033 (USD Million)
Figure 97 Key country dynamics
Figure 98 South Africa targeted DNA RNA sequencing market estimates and forecasts, 2021-2033 (USD Million)
Figure 99 Key country dynamics
Figure 100 Saudi Arabia targeted DNA RNA sequencing market estimates and forecasts, 2021-2033 (USD Million)
Figure 101 Key country dynamics
Figure 102 UAE targeted DNA RNA sequencing market estimates and forecasts, 2021-2033 (USD Million)
Figure 103 Key country dynamics
Figure 104 Kuwait targeted DNA RNA sequencing market estimates and forecasts, 2021-2033 (USD Million)
Figure 105 Market position analysis
Figure 106 Market participant categorization
Figure 107 Strategic framework

Companies Mentioned

The key companies profiled in this Targeted DNA RNA Sequencing market report include:
  • Illumina
  • F. Hoffman-La Roche Ltd.
  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Oxford Nanopore Technologies
  • PierianDx
  • Genomatix GmbH
  • DNASTAR, Inc.
  • Perkin Elmer, Inc.

Table Information